Therapeutic targets and recent advances in protein immunotoxins
Authors:
- Madhumathi JMJMadhumathi J
- Rama S VermaRVRama S Verma
- 1 June 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 15 (3) , 300-309
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer TherapyToxins, 2011
- Therapeutic potential of anticancer immunotoxinsDrug Discovery Today, 2011
- Toxin-Based Therapeutic ApproachesToxins, 2010
- Investigation of a plasmid containing a novel immunotoxin VEGF165‐PE38 gene for antiangiogenic therapy in a malignant glioma modelInternational Journal of Cancer, 2010
- Anti‐cancer activity of anti‐p185HER‐2 ricin A chain immunotoxin on gastric cancer cellsJournal of Gastroenterology and Hepatology, 2010
- Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin BouganinJournal of Immunotherapy, 2009
- Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxinMolecular Cancer Therapeutics, 2008
- Synergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing MiceClinical Cancer Research, 2006
- Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomasBreast Cancer Research, 2005
- Recombinant single‐chain antibody fusion construct targeting human melanoma cells and containing tumor necrosis factorInternational Journal of Cancer, 2003